ClearBridge Investments
PRQR icon

ClearBridge Investments’s ProQR Therapeutics PRQR Stock Holding History

ClearBridge Investments’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-977
Closed -$6K – 934
2020
Q2 		$6K Hold
977
– – ﹤0.01% 910
2020
Q1 		$5K Sell
977
-32
-3% -$245 ﹤0.01% 980
2019
Q4 		$10K Hold
1,009
– – ﹤0.01% 1011
2019
Q3 		$6K Sell
1,009
-489,798
-100% -$3.91M ﹤0.01% 1021
2019
Q2 		$4.47M Sell
490,807
-4,420
-0.9% -$52.1K ﹤0.01% 582
2019
Q1 		$6.87M Buy
495,227
+2,939
+0.6% +$43.9K 0.01% 559
2018
Q4 		$7.77M Sell
492,288
-469
-0.1% -$8.61K 0.01% 549
2018
Q3 		$9.54M Buy
492,757
+190
+0% +$2.02K 0.01% 550
2018
Q2 		$3.6M Sell
492,567
-6,706
-1% -$33.8K ﹤0.01% 541
2018
Q1 		$1.53M Buy
499,273
+80
+0% +$257 ﹤0.01% 607
2017
Q4 		$1.61M Buy
499,193
+135
+0% +$485 ﹤0.01% 610
2017
Q3 		$2.42M Sell
499,058
-1,222
-0.2% -$6.34K ﹤0.01% 573
2017
Q2 		$2.6M Buy
500,280
+804
+0.2% +$4K ﹤0.01% 560
2017
Q1 		$2.5M Buy
499,476
+263
+0.1% +$1.16K ﹤0.01% 589
2016
Q4 		$2.45M Buy
499,213
+279
+0.1% +$1.44K ﹤0.01% 603
2016
Q3 		$3.33M Sell
498,934
-5,345
-1% -$29.4K ﹤0.01% 573
2016
Q2 		$2.44M Buy
504,279
+2,610
+0.5% +$13.4K ﹤0.01% 620
2016
Q1 		$2.45M Buy
501,669
+2,653
+0.5% +$13.5K ﹤0.01% 609
2015
Q4 		$4.33M Buy
499,016
+457
+0.1% +$5.26K 0.01% 563
2015
Q3 		$7.26M Buy
498,559
+493
+0.1% +$8.26K 0.01% 524
2015
Q2 		$8.3M Sell
498,066
-1,121
-0.2% -$21.1K 0.01% 513
2015
Q1 		$10.9M Sell
499,187
-216
-0% -$4.46K 0.01% 491
2014
Q4 		$10.8M Buy
499,403
+101,617
+26% +$1.54M 0.01% 509
2014
Q3 		$6.84M Buy
+397,786
New +$6.37M 0.01% 558

Other funds holding PRQR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ClearBridge Investments's PRQR Position: Q3 2020 in Review

ClearBridge Investments sold out of ProQR Therapeutics (PRQR) in Q3 2020, closing a stake of 977 shares — an estimated $6K sold.

ClearBridge Investments first reported a position in PRQR in Q3 2014 and held it in 24 quarters. The position peaked at $10.9M in Q1 2015. 42 funds tracked by Wall St. Rank hold PRQR as of Q3 2020.

  • ClearBridge Investments reported no remaining ProQR Therapeutics position as of Q3 2020 after selling out during the quarter.
  • ClearBridge Investments sold 977 ProQR Therapeutics shares in Q3 2020, an estimated $6K.
  • ClearBridge Investments first reported a position in ProQR Therapeutics in Q3 2014 and held it in 24 quarters.
  • ClearBridge Investments's ProQR Therapeutics position peaked at $10.9M in Q1 2015.
  • 42 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2020.

Based on ClearBridge Investments's 13F filing for Q3 2020, filed 12 Nov 2020.